Online press briefing
Vaccines: The COVID-19 Case for Public Pharmaceutical Research and Development
Friday, March 20, 2020, 12 noon-12:45 PM EDT
Adam Gaffney, M.D. is Instructor in Medicine at Harvard Medical School and a pulmonologist and critical care physician at the Cambridge Health Alliance (CHA), an organization committed to the health of the underserved. Dr. Gaffney’s healthcare research has been published in the Lancet, the Annals of Internal Medicine, British Medical Journal, Chest, the European Respiratory Journal, and elsewhere. He serves as the President of Physicians for a National Health Program.
Ameet Sarpatwari, Ph.D., J.D. is an Assistant Professor of Medicine at Harvard Medical School, an Associate Epidemiologist at Brigham and Women’s Hospital, and Assistant Director of the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes.
Dana Brown is the Director of the Next System Project at The Democracy Collaborative, a national research and development lab for the democratic economy, and the author of the report Medicine for All: The Case for a Public Option in the Pharmaceutical Industry.
Alex Lawson is the Executive Director of Social Security Works, the convening member of the Strengthen Social Security Coalition—a coalition made up of over 340 national and state organizations representing over 50 million Americans.